MATERIAL SAFETY DATA SHEET - Pfizer
Page 1 of 7 Revision date: 02-Jan-2007 MATERIAL SAFETY data SHEET Version: IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING MATERIAL Name: Cisplatin Solution for Injection - and 1 mg/ml Trade Name: Platamine; Cisplatino; Cisplatine; Platiblastin; Plastisil; Platiblastin S Chemical Family: Mixture Intended Use: Pharmaceutical product used as Antineoplastic 2. COMPOSITION/INFORMATION ON INGREDIENTS HazardousIngredientCAS NumberEU EINECS List% Acid7647-01-0231-595-7**Sodium hydroxide1310-73-2215-185-5** IngredientCAS NumberEU EINECS List%Sodium chloride7647-14-5231-598-3*Water for Injection7732-18-5231-791-2*Mannitol69-6 5-8200-711-8* Additional Information:* Proprietary ** to adjust pH Ingredient(s) indicated as hazardous have been assessed under standards for workplace SAFETY . 3. HAZARDS IDENTIFICATION Appearance:Clear to light yellow solution - mg/mlClear solution - 1 mg/mlSignal Word:WARNING Statement of Hazard:Possible carcinogen and mutagenAdditional Hazard Information: Short Term: May cause eye and skin irritation; May be fatal if swallowed (based on components) Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on kidneys and blood and blood forming org
Revision date: 02-Jan-2007 Page 1 of 7 MATERIAL SAFETY DATA SHEET Version: 1.1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Material Name: Cisplatin Solution for Injection - …
Download MATERIAL SAFETY DATA SHEET - Pfizer
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Emergency Neurological Life Support Traumatic, OSMITROL INTRAVENOUS, Mannitol, MANNITOL INTRAVENOUS, New Zealand Data Sheet, Intravenous, DBL™ OCTREOTIDE INJECTION, Professional Dialysis Nursing Checklist Service, Volume 42, Number 4, pp 378–382 2007 Wolters, Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer Health, Of mannitol in the therapy of